Net profit of Senores Pharmaceuticals rose 11.86% to Rs 17.83 crore in the quarter ended March 2025 as against Rs 15.94 crore during the previous quarter ended March 2024. Sales rose 11.49% to Rs 114.21 crore in the quarter ended March 2025 as against Rs 102.44 crore during the previous quarter ended March 2024.
For the full year,net profit rose 86.20% to Rs 58.56 crore in the year ended March 2025 as against Rs 31.45 crore during the previous year ended March 2024. Sales rose 85.65% to Rs 398.25 crore in the year ended March 2025 as against Rs 214.52 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 114.21 | 102.44 | 11 | 398.25 | 214.52 | 86 |
| OPM % | 17.02 | 21.86 | - | 22.52 | 19.39 | - |
| PBDT | 25.91 | 21.32 | 22 | 87.41 | 34.97 | 150 |
| PBT | 20.68 | 17.61 | 17 | 70.57 | 24.95 | 183 |
| NP | 17.83 | 15.94 | 12 | 58.56 | 31.45 | 86 |